CLINICAL_TRIALS
trial_result
· 2017-08-14
Clinical Trial Update: Safety and Acceptability of Carraguard® in HIV Positive Women and Men [Phase 1]
Summary
This Phase 1 study evaluates the safety and acceptability of Carraguard, a carrageenan-based vaginal microbicide, in HIV-positive men and women.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Population Council | Conditions: HIV Infections | Phase 1 | Status: COMPLETED